This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Prudential (PRU) to Sell Variable Annuity to Fortitude Re
by Zacks Equity Research
Prudential (PRU) agrees to sell its in-force legacy variable annuity block to Fortitude Re for $2.2 billion.
Here's Why You Should Add MetLife (MET) to Your Portfolio Now
by Zacks Equity Research
MetLife (MET) continues to benefit from solid returns stemming from its private equity portfolio, diversified product suite and robust capital position.
AIG's Unit Joins SIMON's Platform, Boosts Annuity Portfolio
by Zacks Equity Research
AIG's unit, AIG Life & Retirement, joins SIMON's platform aimed to extend reach of the former's annuity suite to several U.S. financial professionals.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) continues to benefit from lower expenses, higher earnings from joint venture investments, positive third-party net flows, and prudent capital deployment.
Why Aflac (AFL) Should be Part of Your Investment Portfolio
by Zacks Equity Research
Aflac (AFL) is a promising bet for strong returns, given its reviving sales at the U.S and Japan segments and long-term strategic initiatives.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Is it the Right Time to Add Horace Mann (HMN) to Your Kitty?
by Zacks Equity Research
Horace Mann Educators Corporation (HMN) is poised to gain from niche focus, demographic shift and strategic acquisition.
MetLife (MET) Up 4.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
MetLife (MET) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Why Should You Hold Onto the Pet Insurer Trupanion (TRUP)?
by Zacks Equity Research
Trupanion's (TRUP) long-term growth strategy and the burgeoning pet insurance market make it a stock to hold onto for netting solid long-term gains.
Zacks.com featured highlights include: AdvanSix, Haverty Furniture, ArcBest, MetLife and ASE Technology
by Zacks Equity Research
Zacks.com featured highlights include: AdvanSix, Haverty Furniture, ArcBest, MetLife and ASE Technology
MET or PUK: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MET vs. PUK: Which Stock Is the Better Value Option?
Scoop Up These 7 Low Price-to-Sales Stocks Reflecting Strength
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like FL, MT, NUS, MET, PIPR, KBH, and SMP are promising picks.
Pick These 5 Bargain Stocks With Exciting EV-to-EBITDA Ratios
by Anindya Barman
We have screened bargain stocks ASIX, HVT, ARCB, MET and ASX based on EV-to-EBITDA ratio that offers a clearer picture of valuation and earnings potential.
The Zacks Analyst Blog Highlights: Moody's, Nasdaq, Raymond James Financial, MetLife and T. Rowe Price
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Moody's, Nasdaq, Raymond James Financial, MetLife and T. Rowe Price
MetLife's (MET) Unit Buys Property, Boosts Real Estate Presence
by Zacks Equity Research
MetLife's (MET) institutional asset management business MIM teams up with NBIM for acquiring a high-quality office property in Massachusetts for $825.1 million.
5 Stocks to Buy From Top Performing S&P 500 Finance Sector
by Swayta Shah
The Finance sector will keep witnessing impressive performance on the back of bullish investor sentiments. Let's check out Moody's (MCO), Nasdaq (NDAQ), Raymond James (RJF), MetLife (MET) & T. Rowe Price (TROW) that have solid growth prospects.
The Zacks Analyst Blog Highlights: Blackstone, ConocoPhillips, EOG Resources, MetLife and American International Group
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Blackstone, ConocoPhillips, EOG Resources, MetLife and American International Group
Primerica (PRI) Stock Up 13% YTD: Can it Retain the Momentum?
by Zacks Equity Research
A compelling portfolio, strong market presence, and sturdy financial position continue to drive Primerica (PRI).
Old Republic (ORI) Stock Up 34% YTD: More Room for Upside?
by Zacks Equity Research
Its position among title insurance providers to residential and commercial markets, niche focus, low property catastrophe exposure at its General Insurance segment, and solid capital position continue to drive Old Republic International (ORI).
Top 5 High-Yielding Stock Market Gainers YTD With More Upside
by Nalak Das
We have narrowed down our search to five large-cap stocks (market capital >$30 billion) that have popped more than 30% year to date. These are: AIG, MET, BX, COP and EOG.
Are Investors Undervaluing MetLife (MET) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
The Zacks Analyst Blog Highlights: American International Group, Cincinnati Financial Corp., Marsh & McLennan, MetLife and Aflac
by Zacks Equity Research
The Zacks Analyst Blog Highlights: American International Group, Cincinnati Financial Corp., Marsh & McLennan, MetLife and Aflac
Top 5 Picks From S&P 500's Best Sector in the Past Month
by Nalak Das
We have narrowed down our search to five large-cap insurers that have strong growth potential for the rest of 2021. These are: AFL, AIG, MMC, MET and CINF.
Reasons That Make the Stock of MetLife (MET) Attractive Now
by Zacks Equity Research
Economic growth, receding COVID woes, strategic initiatives, balance sheet strength and a consistent dividend payment history make MetLife (MET) a good stock pick.
7 Low Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.